An Important Step for RWE in China: China CDE published the Draft Key Considerations in Using Real-World Evidence to Support Drug Development
On May 29th, 2019, China CDE published the Key Considerations in Using Real-World Evidence to Support Drug Development (Draft Version) for public review. And it’s the first time the concept of Real World Evidence (RWE) was clearly stated by China CDE. This Key Considerations (Draft) contains five main parts including 1) Introduction, 2) The Definition…